يعرض 1 - 20 نتائج من 35 نتيجة بحث عن '"Jones-leone, Angela"', وقت الاستعلام: 0.40s تنقيح النتائج
  1. 1
    Academic Journal
    Effect of belimumab on kidney-related outcomes in patients with lupus nephritis: post hoc subgroup analyses of the phase 3 BLISS-LN trial

    المؤلفون: Anders, Hans-Joachim, Furie, Richard, Malvar, Ana, Zhao, Ming-Hui, Hiromura, Keiju, Weinmann-Menke, Julia, Green, Yulia, Jones-Leone, Angela, Negrini, Daniela, Levy, Roger A, Lightstone, Liz, Tanaka, Yoshiya, Rovin, Brad H

    المساهمون: GSK

    المصدر: Nephrology Dialysis Transplantation ; volume 38, issue 12, page 2733-2742 ; ISSN 0931-0509 1460-2385

    الاتاحة: http://dx.doi.org/10.1093/ndt/gfad167
    https://academic.oup.com/ndt/advance-article-pdf/doi/10.1093/ndt/gfad167/51052615/gfad167.pdf
    https://academic.oup.com/ndt/article-pdf/38/12/2733/53959677/gfad167.pdf

    View record in BASE

    أضف إلى المفضلة
  2. 2
    Academic Journal
    MOONLIGHT study: the design of a comparative study of the effectiveness of belimumab in patients with a history of lupus nephritis from the post-Marketed effectiveness of belimumab cOhOrt and JapaN Lupus NatIonwide reGistry (LUNA) coHorT

    المؤلفون: Sada, Kenei, Kurita, Noriaki, Noma, Hisashi, Matsuki, Taizo, Quasny, Holly, Levy, Roger A, Jones-Leone, Angela R, Gairy, Kerry, Yajima, Nobuyuki

    المساهمون: GSK

    المصدر: Lupus Science & Medicine ; volume 9, issue 1, page e000746 ; ISSN 2053-8790

    الاتاحة: http://dx.doi.org/10.1136/lupus-2022-000746
    https://syndication.highwire.org/content/doi/10.1136/lupus-2022-000746

    View record in BASE

    أضف إلى المفضلة
  3. 3
    Academic Journal
    10 Years of belimumab experience: What have we learnt?

    المؤلفون: Levy, Roger A, Gonzalez-Rivera, Tania, Khamashta, Munther, Fox, Norma Lynn, Jones-Leone, Angela, Rubin, Bernie, Burriss, Susan W, Gairy, Kerry, Maurik, Andre van, Roth, David A

    المساهمون: GlaxoSmithKline

    المصدر: Lupus ; volume 30, issue 11, page 1705-1721 ; ISSN 0961-2033 1477-0962

    الاتاحة: https://doi.org/10.1177/09612033211028653
    https://journals.sagepub.com/doi/pdf/10.1177/09612033211028653
    https://journals.sagepub.com/doi/full-xml/10.1177/09612033211028653

    View record in BASE

    أضف إلى المفضلة
  4. 4
    Academic Journal
    FC 034SAFETY AND EFFICACY OF INTRAVENOUS BELIMUMAB IN PATIENTS WITH LUPUS NEPHRITIS: A 6-MONTH OPEN-LABEL EXTENSION

    المؤلفون: Rovin, Brad, Furie, Richard, Houssiau, Frédéric A, Contreras, Gabriel, Teng, Y K O, Curtis, Paula, Madan, Anuradha, Jones-leone, Angela, Gonzalez-Rivera, Tania, Okily, Mohamed, Roth, David

    المصدر: Nephrology Dialysis Transplantation ; volume 36, issue Supplement_1 ; ISSN 0931-0509 1460-2385

    الاتاحة: https://doi.org/10.1093/ndt/gfab121.003
    http://academic.oup.com/ndt/article-pdf/36/Supplement_1/gfab121.003/38382063/gfab121.003.pdf

    View record in BASE

    أضف إلى المفضلة
  5. 5
    Academic Journal
    The role of baseline BLyS levels and type 1 interferon-inducible gene signature status in determining belimumab response in systemic lupus erythematosus: a post hoc meta-analysis

    المؤلفون: Wilkinson, Christel, Henderson, Robert B., Jones-Leone, Angela R., Flint, Shaun M., Lennon, Mark, Levy, Roger A., Ji, Beulah, Bass, Damon L., Roth, David

    المساهمون: GSK

    المصدر: Arthritis Research & Therapy ; volume 22, issue 1 ; ISSN 1478-6362

    الاتاحة: http://dx.doi.org/10.1186/s13075-020-02177-0
    https://link.springer.com/content/pdf/10.1186/s13075-020-02177-0.pdf
    https://link.springer.com/article/10.1186/s13075-020-02177-0/fulltext.html

    View record in BASE

    أضف إلى المفضلة
  6. 6
    Academic Journal
    Hemoglobin Stability in the ASCEND-TD Trial ; SA-OR53

    المؤلفون: Acharya, Anjali, Rastogi, Anjay, Jha, Vivekanand, Singh, Ajay K., Meadowcroft, Amy M., Bhatt, Purav R., Jones-Leone, Angela R., Shannon, Jennifer

    المصدر: Journal of the American Society of Nephrology ; volume 34, issue 11S, page 75-76 ; ISSN 1046-6673

    الاتاحة: http://dx.doi.org/10.1681/asn.20233411s175d
    https://journals.lww.com/10.1681/ASN.20233411S175d

    View record in BASE

    أضف إلى المفضلة
  7. 7
    Academic Journal
    Post Hoc Analyses of Biomarkers Predictive of a Renal Response to Intravenous (IV) Belimumab (BEL) Plus Standard Therapy (ST) in Patients with Lupus Nephritis (LN) ; SA-PO881

    المؤلفون: Rovin, Brad H., Furie, Richard, Malvar, Ana, Aranow, Cynthia, Pego-Reigosa, José M., Zakharova, Elena, Schwarting, Andreas, Jones-Leone, Angela R., Gilbride, Jennifer A., Ji, Beulah, Roth, David A., Curtis, Paula S., Maurik, André van

    المصدر: Journal of the American Society of Nephrology ; volume 34, issue 11S, page 972-973 ; ISSN 1046-6673

    الاتاحة: http://dx.doi.org/10.1681/asn.20233411s1972c
    https://journals.lww.com/10.1681/ASN.20233411S1972c

    View record in BASE

    أضف إلى المفضلة
  8. 8
    Academic Journal
    Drug-Drug Interaction Between Phosphate Binders and Daprodustat in ASCEND-D ; SA-PO255

    المؤلفون: Stankus, Nicole S., Meadowcroft, Amy M., Bhatt, Nisha, Jones-Leone, Angela R., Bhatt, Purav R., Shannon, Jennifer, Singh, Ajay K.

    المصدر: Journal of the American Society of Nephrology ; volume 34, issue 11S, page 793-793 ; ISSN 1046-6673

    الاتاحة: http://dx.doi.org/10.1681/asn.20233411s1793a
    https://journals.lww.com/10.1681/ASN.20233411S1793a

    View record in BASE

    أضف إلى المفضلة
  9. 9
    Academic Journal
    Albiglutide efficacy and safety in the Latino/Hispanic subpopulation for the integrated phase III program

    المؤلفون: Davidson, Jaime A., Jones-Leone, Angela, Wilson, Timothy H., Nino, Antonio, Forero-Schwanhaeuser, Sergio, Reinhardt, Rickey R.

    المساهمون: GlaxoSmithKline

    المصدر: Postgraduate Medicine ; volume 129, issue 8, page 849-857 ; ISSN 0032-5481 1941-9260

    الاتاحة: https://doi.org/10.1080/00325481.2017.1387473
    https://www.tandfonline.com/doi/pdf/10.1080/00325481.2017.1387473

    View record in BASE

    أضف إلى المفضلة
  10. 10
    Academic Journal
    Efficacy and safety of once-weekly GLP-1 receptor agonist albiglutide (HARMONY 2): 52 week primary endpoint results from a randomised, placebo-controlled trial in patients with type 2 diabetes mellitus inadequately controlled with diet and exercise

    المؤلفون: Nauck, Michael A., Stewart, Murray W., Perkins, Christopher, Jones-Leone, Angela, Yang, Fred, Perry, Caroline, Reinhardt, Rickey R., Rendell, Marc

    المساهمون: GlaxoSmithKline

    المصدر: Diabetologia ; volume 59, issue 2, page 266-274 ; ISSN 0012-186X 1432-0428

    الاتاحة: http://dx.doi.org/10.1007/s00125-015-3795-1
    http://link.springer.com/content/pdf/10.1007/s00125-015-3795-1.pdf
    http://link.springer.com/article/10.1007/s00125-015-3795-1/fulltext.html
    http://link.springer.com/content/pdf/10.1007/s00125-015-3795-1

    View record in BASE

    أضف إلى المفضلة
  11. 11
    Academic Journal
    Effects of Belimumab (BEL) on Renal Outcomes in Patients (pts) with Relapsed and Newly Diagnosed Active Lupus Nephritis (LN) ; SA-OR32

    المؤلفون: Anders, Hans J., Rovin, Brad H., Zhao, Ming Hui, Malvar, Ana, Hiromura, Keiju, Jones-Leone, Angela R., González-Rivera, Tania, Gilbride, Jennifer A., Madan, Anuradha, Green, Yulia, Roth, David A.

    المصدر: Journal of the American Society of Nephrology ; volume 32, issue 10S, page 48-49 ; ISSN 1046-6673

    الاتاحة: http://dx.doi.org/10.1681/asn.20213210s148c
    https://journals.lww.com/10.1681/ASN.20213210S148c

    View record in BASE

    أضف إلى المفضلة
  12. 12
    Additional file 6 of The role of baseline BLyS levels and type 1 interferon-inducible gene signature status in determining belimumab response in systemic lupus erythematosus: a post hoc meta-analysis

    المؤلفون: Wilkinson, Christel, Henderson, Robert B., Jones-Leone, Angela R., Flint, Shaun M., Lennon, Mark, Levy, Roger A., Ji, Beulah, Bass, Damon L., Roth, David

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::540e6bd81f34b5e2d0eb1e9fdac18b13

    View record in OpenAIRE

    أضف إلى المفضلة
  13. 13
    Additional file 3 of The role of baseline BLyS levels and type 1 interferon-inducible gene signature status in determining belimumab response in systemic lupus erythematosus: a post hoc meta-analysis

    المؤلفون: Wilkinson, Christel, Henderson, Robert B., Jones-Leone, Angela R., Flint, Shaun M., Lennon, Mark, Levy, Roger A., Ji, Beulah, Bass, Damon L., Roth, David

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8569585b1d5266562a8b921af73f20a0

    View record in OpenAIRE

    أضف إلى المفضلة
  14. 14
    Additional file 7 of The role of baseline BLyS levels and type 1 interferon-inducible gene signature status in determining belimumab response in systemic lupus erythematosus: a post hoc meta-analysis

    المؤلفون: Wilkinson, Christel, Henderson, Robert B., Jones-Leone, Angela R., Flint, Shaun M., Lennon, Mark, Levy, Roger A., Ji, Beulah, Bass, Damon L., Roth, David

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::213cbd60efbebe257222fb7fb8f378f5

    View record in OpenAIRE

    أضف إلى المفضلة
  15. 15
    Additional file 5 of The role of baseline BLyS levels and type 1 interferon-inducible gene signature status in determining belimumab response in systemic lupus erythematosus: a post hoc meta-analysis

    المؤلفون: Wilkinson, Christel, Henderson, Robert B., Jones-Leone, Angela R., Flint, Shaun M., Lennon, Mark, Levy, Roger A., Ji, Beulah, Bass, Damon L., Roth, David

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d52e34ed1f709b1c284f97b50ffba52

    View record in OpenAIRE

    أضف إلى المفضلة
  16. 16
    Additional file 9 of The role of baseline BLyS levels and type 1 interferon-inducible gene signature status in determining belimumab response in systemic lupus erythematosus: a post hoc meta-analysis

    المؤلفون: Wilkinson, Christel, Henderson, Robert B., Jones-Leone, Angela R., Flint, Shaun M., Lennon, Mark, Levy, Roger A., Ji, Beulah, Bass, Damon L., Roth, David

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e28cd6a5f199452210a2a047090358b

    View record in OpenAIRE

    أضف إلى المفضلة
  17. 17
    Additional file 4 of The role of baseline BLyS levels and type 1 interferon-inducible gene signature status in determining belimumab response in systemic lupus erythematosus: a post hoc meta-analysis

    المؤلفون: Wilkinson, Christel, Henderson, Robert B., Jones-Leone, Angela R., Flint, Shaun M., Lennon, Mark, Levy, Roger A., Ji, Beulah, Bass, Damon L., Roth, David

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fa253c3ee6f6fc8142b438d83af9aa8

    View record in OpenAIRE

    أضف إلى المفضلة
  18. 18
    Additional file 8 of The role of baseline BLyS levels and type 1 interferon-inducible gene signature status in determining belimumab response in systemic lupus erythematosus: a post hoc meta-analysis

    المؤلفون: Wilkinson, Christel, Henderson, Robert B., Jones-Leone, Angela R., Flint, Shaun M., Lennon, Mark, Levy, Roger A., Ji, Beulah, Bass, Damon L., Roth, David

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05ad9b7221c45da86ec979325a797aca

    View record in OpenAIRE

    أضف إلى المفضلة
  19. 19
    Academic Journal
    1.4 Harmony 8: Once Weekly (QW) GLP1 Agonist Albiglutide (Albi) vs. Sitagliptin (Sita) in Type 2 Diabetes (T2D) Pts With Renal Impairment (RI): Week 26 Results (68-OR)

    المؤلفون: Leiter, Lawrence A., Carr, Molly C., Stewart, Murray, Jones-Leone, Angela R., Yang, Fred, Handelsman, Yehuda

    المصدر: Nederlands Tijdschrift voor Diabetologie ; volume 11, issue 3, page 76-77 ; ISSN 1567-2743 1876-6242

    الاتاحة: http://dx.doi.org/10.1007/s12467-013-0029-3
    http://link.springer.com/content/pdf/10.1007/s12467-013-0029-3.pdf
    http://link.springer.com/article/10.1007/s12467-013-0029-3/fulltext.html
    http://link.springer.com/content/pdf/10.1007/s12467-013-0029-3

    View record in BASE

    أضف إلى المفضلة
  20. 20
    Academic Journal
    Efficacy and safety of once-weekly GLP-1 receptor agonist albiglutide (HARMONY 2): 52 week primary endpoint results from a randomised, placebo-controlled trial in patients with type 2 diabetes mellitus inadequately controlled with diet and exercise.

    المؤلفون: Nauck, Michael, Stewart, Murray, Perkins, Christopher, Jones-Leone, Angela, Yang, Fred, Perry, Caroline, Reinhardt, Rickey, Rendell, Marc

    المصدر: Diabetologia; Feb2016, Vol. 59 Issue 2, p266-274, 9p, 1 Diagram, 2 Charts, 2 Graphs

    Full Text Finder

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء